Replies to post #102907 on Biotech Values

[DewDiligence]

When will NVS [Lovenox] shipments stabilize at their manufacturing limits (i.e. 2 quarters back to back above 35% of current total Lovenox demand)>

NVS’ manufacturing capacity will be rising, so this is a moving target. I’m content to wait until Oct 21, when NVS itself will presumably provide some guidance.